Salesforce Friends ...
Health Care: Drugs
Chelsea Therapeutics International Ltd. (CHTP: NASDAQ)
$1.35 0.00 | 0.00%
06/04/12 - 04:00 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 41.11M | 47.59M | 22.29M | 21.53M |
| Receivables | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 46.57M | 48.16M | 34.17M | 32.57M |
| Property, Plant & Equipment, Gross | 683.23K | 455.76K | 303.93K | 290.00K |
| Accumulated Depreciation & Depletion | 392.21K | 275.74K | 200.14K | 131.00K |
| Property, Plant & Equipment, Net | 291.02K | 180.02K | 103.80K | 159.00K |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 38.27K | 38.10K | 76.95K | 11.41M |
| Total Non-Current Assets | 329.29K | 218.12K | 180.74K | 11.56M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 46.90M | 48.37M | 34.35M | 44.13M |
| Accounts Payable | 4.87M | 2.29M | 2.84M | 4.30M |
| Short Term Debt | 0.00 | 0.00 | 11.47M | 0.00 |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 13.24M | 13.19M | 21.50M | 12.30M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 7.28M |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 7.28M |
| Total Liabilities | 13.24M | 13.19M | 21.50M | 19.58M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 33.66M | 35.19M | 12.85M | 24.55M |
| Common Par | 6.20K | 4.98K | 3.35K | 3.00K |
| Additional Paid In Capital | 216.98M | 168.06M | 108.39M | 94.32M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -183.33M | -132.87M | -95.54M | -69.77M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Capitalization | 33.66M | 35.19M | 12.85M | 31.82M |
| Total Equity | 33.66M | 35.19M | 12.85M | 24.55M |
| Total Liabilities & Stock Equity | 46.90M | 48.37M | 34.35M | 44.13M |
| Total Common Shares Outstanding | 62.03M | 49.79M | 33.50M | 30.11M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 60.14M | 41.18M | 31.55M | 30.03M |
| Diluted Weighted Shares Outstanding | 60.14M | 41.18M | 31.55M | 30.03M |
| Number of Employees | 49 | 30 | 18 | 17 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with CHTP
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- UserLA
- ContributorBreakout Stocks Of The Week...
- ContributorBreakout Stocks Of The Week...
- Contributor10 Pharma Stocks With 100% ...
- UserLIGDOGS
- UserSharebuilder
Latest CHTP Headlines from TheStreet
- Chelsea Therapeutics' CEO Discusses Completion Of EoR Meeting With FDA For Northera Capsules NDA (Transcript) 05.23.12 | 07:05 am
- Chelsea Therapeutics' CEO Discusses Chelsea Therapeutics Receives Complete Response Letter From Food And Drug Administration For Northera(TM) (droxidopa) Capsules (Transcript) 03.29.12 | 01:03 pm
- Biotech Stock Mailbag: Xoma's Big Backers, FDA Approvals Contest 03.23.12 | 05:03 am
- The Next Big Thing in Biotech: FDA Decisions
03.23.12 | 05:03 am - Biotech Stock Chat: Recap 03.15.12 | 11:03 am
- Chelsea Therapeutics International's CEO Discusses Q4 2011 Results - Earnings Call Transcript 03.06.12 | 07:03 pm
- Chelsea Therapeutics' CEO Presents FDA Advisory Committee Update - Conference Call (Transcript) 02.29.12 | 09:02 pm
- Wednesday's Top 10 Articles, Videos on TheStreet 02.29.12 | 01:02 pm
- Biotech Twitter Mailbag: Gilead, Chelsea, Keryx, Onyx, BioSante, Dendreon 02.29.12 | 06:02 am
- Monday's Top 10 Articles, Videos on TheStreet 02.27.12 | 02:02 pm
Press Releases for CHTP
- Faruqi & Faruqi, LLP Notifies Investors Of June 4, 2012 Lead Plaintiff Deadline For The Class Action Filed Against Chelsea Therapeutics International - PR Newswire 05.29.12 | 07:05 pm
- Chelsea Therapeutics International Lead Plaintiff Deadline - June 4, 2012: Levi & Korsinsky Reminds Investors With Losses On Their Investment In Chelsea Therapeutics International Of Class Action And The Lead Plaintiff Deadline - Business Wire 05.29.12 | 02:05 pm
- Upcoming Deadline: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Chelsea Therapeutics International Ltd. Of Class Action Lawsuit And The Deadline Of June 4, 2012 To Seek A Lead Plaintiff Position - PR Newswire 05.21.12 | 02:05 pm
- Upcoming Deadline: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Chelsea Therapeutics International Ltd. Of Class Action Lawsuit And The Deadline Of June 4, 2012 To Seek A Lead Plaintiff Position - Business Wire 04.30.12 | 04:04 pm
- Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In Chelsea Therapeutics International, Ltd. To Contact The Firm - PR Newswire 04.20.12 | 07:04 pm
- Chelsea Therapeutics International Shareholder Alert: The Briscoe Law Firm And Powers Taylor, LLP Investigate Possible Breaches Of Fiduciary Duty By The Officers And Directors Of Chelsea Therapeutics International, Ltd. - Business Wire 04.11.12 | 10:04 am
- Faruqi & Faruqi, LLP Announces Investigation Of Chelsea Therapeutics International, Ltd. - PR Newswire 04.05.12 | 07:04 pm
- Upcoming Deadline: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Chelsea Therapeutics International Ltd. Of Class Action Lawsuit And The Deadline Of June 4, 2012 To Seek A Lead Plaintiff Position - Business Wire 04.05.12 | 04:04 pm
- Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Chelsea Therapeutics International, Ltd. - Business Wire 04.05.12 | 12:04 pm
- Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Chelsea Therapeutics International, Ltd. - Business Wire 02.21.12 | 08:02 am
Partner Headlines for CHTP
- How To Play Chelsea Therapeutics - Seeking Alpha 03.09.12 | 04:03 pm
- 5 High-Risk, High-Reward Biopharma Stocks - Seeking Alpha 02.14.12 | 09:02 am
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
- 10 Biotech Stocks With Strong Corporate Governance - Seeking Alpha 01.18.12 | 09:01 am
- Friday Options Recap - Seeking Alpha 12.23.11 | 03:12 pm
- 6 Biotechs That Could See Huge Gains (Like Inhibitex) - Seeking Alpha 11.11.11 | 09:11 am
- 5 Healthcare Stocks of Interest This Week - Seeking Alpha 07.27.11 | 09:07 am
- Top 30 Rallying Small Cap Stocks With Significant Institutional Buying - Seeking Alpha 06.29.11 | 09:06 am
- 10 Undervalued Biotech Stocks With Insider Buying - Seeking Alpha 06.23.11 | 06:06 am
- 6 Cash Rich Biotech Stocks With Catalysts - Seeking Alpha 04.08.11 | 08:04 am
